Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dan Qi Tong Mai tablet
- Development stage
- Unknown
- Lead developer
- Shanghai Institute of Materia Medica
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Dan Qi Tong Mai tablet (DQTM) is an innovative traditional Chinese medicine (TCM) formulation developed for the treatment of cardiovascular diseases, specifically coronary heart disease and chronic stable angina pectoris (blood stasis syndrome). It is composed of active fractions of *Salvia miltiorrhiza* (Danshen) salvianolic acids and *Panax notoginseng* (Sanqi) saponins (notoginsengnosides). The formulation was co-developed by the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, and Taiji Group. DQTM has completed Phase I clinical trials evaluating its safety, tolerability, and pharmacodynamics in healthy volunteers (conducted at West China Hospital, Sichuan University), and is currently in Phase II clinical development.
- Other names
- Danqi Tongmai tabletDQTM tabletDQTT丹七通脉片
02
Targets
15-LOX (Lysyl Oxidase)COXPARP1 (Poly (adp-ribose) polymerase 1)
Beyond the preview
Go deeper on Dan Qi Tong Mai tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dan Qi Tong Mai tablet.